Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olymic-ro 43-gil, Songpa-gu, Seoul, 138-736, Republic of Korea.
Department of Otorhinolaryngology-Head & Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olymic-ro 43-gil, Songpa-gu, Seoul, 138-736, Republic of Korea.
Eur Radiol. 2018 Mar;28(3):910-919. doi: 10.1007/s00330-017-5040-4. Epub 2017 Sep 27.
To prospectively evaluate the technical feasibility and safety of fluoroscopy-guided balloon dilation in patients with Eustachian tube (ET) dysfunction.
Patients who could not do a Valsalva manoeuvre for more than 6 months and diagnosed with chronic otitis media or ET dysfunction were prospectively enrolled. A 0.035-in. guide wire and 6-mm long balloon catheter with a diameter of 2 mm were used to dilate the cartilaginous portion of the ET under fluoroscopic guidance. The balloon was inflated by manual injection twice for 1 min each time. Clinical outcomes were assessed by the patient's ability to perform a Valsalva manoeuvre, and symptoms were assessed using the 7-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) score.
Balloon dilation was attempted in a total of ten adult patients from October 2016 to March 2017. Technical success was achieved in all procedures (10/10). Ninety percent (9/10) of the balloons were fully dilated without waist deformity. There were no major complications. All patients were able to perform a Valsalva manoeuvre at the time of their last visit and/or improvement of at least one ETDQ-7 score.
Fluoroscopy-guided balloon dilation seems to be technically feasible and safe in the treatment of ET dysfunction.
• Fluoroscopy-guided balloon dilation without general anaesthesia was well-tolerated in all patients. • Location of the balloon catheter can be monitored during the procedure. • Inflation state of the balloon catheter can be monitored during the procedure. • Using guide-wire during the procedure would prevent false passage creation. • All patients had clinical improvement within 3 months after balloon dilation.
前瞻性评估球囊扩张在咽鼓管(ET)功能障碍患者中的技术可行性和安全性。
前瞻性纳入无法进行超过 6 个月瓦尔萨尔瓦动作且诊断为慢性中耳炎或 ET 功能障碍的患者。在透视引导下,使用 0.035 英寸导丝和 6 毫米长、直径 2 毫米的球囊导管扩张 ET 的软骨部分。通过手动注射将球囊充气两次,每次 1 分钟。通过患者行瓦尔萨尔瓦动作的能力和 7 项咽鼓管功能障碍问卷(ETDQ-7)评分来评估临床结果。
2016 年 10 月至 2017 年 3 月,共对 10 例成年患者尝试进行球囊扩张。所有手术均获得技术成功(10/10)。90%(9/10)的球囊完全扩张,无腰变形。无重大并发症。所有患者在最后一次就诊时均能够行瓦尔萨尔瓦动作,或 ETDQ-7 评分至少提高 1 分。
透视引导下球囊扩张治疗 ET 功能障碍似乎具有技术可行性和安全性。
• 所有患者均能耐受透视引导下非全身麻醉的球囊扩张。• 可在手术过程中监测球囊导管的位置。• 可在手术过程中监测球囊导管的充气状态。• 手术过程中使用导丝可防止假性通道形成。• 所有患者在球囊扩张后 3 个月内均有临床改善。